P

Protagonist Therapeutics

97 employees

Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2006

Funding rounds raised

Total raised

$50M

from 15 investors over 15 rounds

P

Protagonist Therapeutics raised $50M on October 31, 2019

Investors: MidCap Financial

P

Protagonist Therapeutics raised $1.5M on September 6, 2018

Investors: National Institutes of Health

P

Protagonist Therapeutics raised $1.3M on May 24, 2017

Investors: National Institutes of Health

P

Protagonist Therapeutics raised $40M on July 16, 2015

Investors: Adage Capital Management, Canaan, Inbio Ventures, RA Capital Management, L.P., Lilly Ventures, Foresite Capital and Starfish Ventures

P

Protagonist Therapeutics raised $14M on June 4, 2013

Investors: Starfish Ventures, Inbio Ventures and Lilly Ventures

P

Protagonist Therapeutics raised $9M on September 19, 2006

Investors: Lilly Ventures and Starfish Ventures

FAQ